We are live on ! Find out more
WVP

Worth Venture Partners Portfolio holdings

AUM $31.6M
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
+4.91%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$15M
AUM Growth
-$170M
Cap. Flow
-$69.6M
Cap. Flow %
-462.87%
Top 10 Hldgs %
51.84%
Holding
132
New
31
Increased
18
Reduced
10
Closed
70

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$1.45M
2
IHI icon
iShares US Medical Devices ETF
IHI
+$875K
3
RDCM icon
Radcom
RDCM
+$577K
4
APLS
Apellis Pharmaceuticals
APLS
+$491K
5
INSM icon
Insmed
INSM
+$431K

Top Sells

Rank Stock Value
1
MYO icon
Myomo
MYO
+$7M
2
ASPN icon
Aspen Aerogels
ASPN
+$6.96M
3
INDI icon
indie Semiconductor
INDI
+$4.63M
4
SCPH
scPharmaceuticals
SCPH
+$4.31M
5
TGAN
Transphorm, Inc. Common Stock
TGAN
+$4.21M

Sector Composition

Rank Sector Weight
1 Healthcare 29.82%
2 Technology 27.27%
3 Real Estate 20.31%
4 Communication Services 5.72%
5 Consumer Staples 2.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JNJ icon
1
Johnson & Johnson
JNJ
$635B
$1.44M 9.57%
+9,100
New +$1.45M
AIP icon
2
Arteris
AIP
$1.4B
$1.01M 6.75%
138,591
+28,670
+26% +$185K
IHI icon
3
iShares US Medical Devices ETF
IHI
$3.02B
$908K 6.04%
+15,500
New +$875K
ITI
4
DELISTED
Iteris, Inc.
ITI
$870K 5.78%
176,038
-102,752
-37% -$508K
WEAV icon
5
Weave Communications
WEAV
$491M
$807K 5.36%
70,254
-24,650
-26% -$296K
SSTI icon
6
SoundThinking
SSTI
$107M
$746K 4.96%
46,984
+5,763
+14% +$110K
RDCM icon
7
Radcom
RDCM
$218M
$659K 4.39%
+59,091
New +$577K
CTO
8
CTO Realty Growth
CTO
$743M
$480K 3.19%
28,302
– –
APLS
9
DELISTED
Apellis Pharmaceuticals
APLS
$453K 3.01%
+7,700
New +$491K
INSM icon
10
Insmed
INSM
$23.2B
$418K 2.78%
+15,400
New +$431K
SRPT icon
11
CALL
Sarepta Therapeutics
SRPT
$1.66B
$417K 2.77%
70,600
+5,200
+8% +$637K
NVO
12
Novo Nordisk
NVO
$216B
$385K 2.56%
+3,000
New +$357K
EGAN icon
13
eGain
EGAN
$176M
$370K 2.46%
57,412
+23,071
+67% +$158K
WSR
14
DELISTED
Whitestone REIT
WSR
$343K 2.28%
27,350
+900
+3% +$11.1K
EQC
15
DELISTED
Equity Commonwealth
EQC
$341K 2.27%
18,053
– –
PLYM
16
DELISTED
Plymouth Industrial REIT
PLYM
$329K 2.18%
14,600
+2,200
+18% +$49K
EPR icon
17
EPR Properties
EPR
$4.86B
$312K 2.08%
7,350
+1,900
+35% +$82.8K
AIOT
18
PowerFleet Inc
AIOT
$500M
$300K 2%
56,244
+10,404
+23% +$35.2K
NSA
19
DELISTED
National Storage Affiliates Trust
NSA
$270K 1.8%
6,900
-1,000
-13% -$37.6K
SPG icon
20
Simon Property Group
SPG
$74.5B
$258K 1.72%
1,650
– –
KRG icon
21
Kite Realty
KRG
$5.95B
$249K 1.66%
11,500
+2,000
+21% +$43K
ALCO icon
22
Alico
ALCO
$286M
$244K 1.62%
+8,338
New +$238K
BDN
23
Brandywine Realty Trust
BDN
$551M
$240K 1.6%
50,000
+2,500
+5% +$11.6K
ADC icon
24
Agree Realty
ADC
$9.68B
$231K 1.54%
4,050
+500
+14% +$29.3K
ITCI
25
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$228K 1.52%
+3,300
New +$227K
1
2 3 4 5

Similar funds

VL
Vorpal LLC Nashville, Tennessee $32M AUM 10.89% 1-Year Est. Return
WTG
West Tower Group Richmond, Virginia $32.1M AUM 33.19% 1-Year Est. Return
QCA
Quantify Chaos Advisors Brooklyn, New York $32.1M AUM
SP
SCF Partners Houston, Texas $32.2M AUM 191.71% 1-Year Est. Return
OGC
One68 Global Capital New York $30.9M AUM
PE
Platinum Equity Beverly Hills, California $32.3M AUM 17.64% 1-Year Est. Return
RL
RPO LLC Stamford, Connecticut $32.3M AUM 14.17% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return

Worth Venture Partners's Q1 2024 Portfolio in Review

As of Q1 2024, Worth Venture Partners held 132 positions worth $15M, down 92% from $185M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Worth Venture Partners withdrew a net $69.6M in Q1 2024, closing 70 positions and reducing 10 holdings. Its most notable exit was Myomo, an estimated $7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 21% a quarter earlier, followed by Technology and Real Estate.

Against the trend, Worth Venture Partners opened a new position in Johnson & Johnson worth $1.44M.

  • Worth Venture Partners's largest Q1 2024 buy was Johnson & Johnson: 9,100 shares worth $1.44M.
  • Worth Venture Partners added most to Arteris in Q1 2024, an estimated $185K increase.
  • Worth Venture Partners's biggest Q1 2024 reduction was scPharmaceuticals, cutting an estimated $4.31M.
  • Worth Venture Partners fully exited Myomo in Q1 2024, selling an estimated $7M.
  • Worth Venture Partners's ten largest holdings make up 52% of its $15M portfolio in Q1 2024.
  • Worth Venture Partners opened 31 new positions and closed 70 in Q1 2024.
  • Worth Venture Partners's portfolio value fell 92% quarter-over-quarter to $15M.

Based on Worth Venture Partners's 13F filing for Q1 2024, filed 13 May 2024.